Wegener's granulomatosis.
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood; D001157:Arterial Occlusive Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D018450:Disease Progression; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D053146:Myeloblastin; D010750:Phosphoproteins; D010488:Polyarteritis Nodosa / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D012697:Serine Endopeptidases / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000378:metabolism; D014763:Viral Matrix Proteins
D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents; D010750:Phosphoproteins; D014409:Tumor Necrosis Factor-alpha; D014763:Viral Matrix Proteins; C056367:pp150 protein, Cytomegalovirus; D012697:Serine Endopeptidases; D053146:Myeloblastin